Zunsemetinib

Overview

Zunsemetinib (CDD-450) is an orally active and selective p38α mitogen-activated protein kinase-activated protein kinase 2 ( MK2 ) pathway inhibitor. Zunsemetinib can be used for the research of immuno-inflammatory diseases.

Application

Products | Products > Disease Areas > Inflammation or Immune System Disease | Products > Signaling Pathways > MAPK/ERK Pathway | Products > Research Areas > Inflammation/Immunology | Products > Signaling Pathways > MAPKAPK2 (MK2)

Product Information

• Catalog No.: HY-139553
• CAS No.: 1640282-42-3
• Molecular Formula: C25H22ClF2N5O3
• Molecular Weight: 513.92
• Purity: 99.99%
• Storage: Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month
• Solubility: ≥ 2.5 mg/mL (4.86 mM); Clear solution
• Availability: In-stock

Source

Original product source